The kinetics of HLA class I elution and the relevance for the use of HLA-eluted platelet transfusions

British Journal of Haematology

Volumn 95, Issue 2, 1996, Pages 416-422

  Novotny, V M J ^a,c   Doxiadis, I N N ^b   Van Doorn, R ^a   Brand, A ^a,b  

^a Red Cross Bloodbank Leiden   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CENTRAL LABORATORY   (Netherlands)

Author keywords

HLA elution; Kinetics; Platelet transfusion

Indexed keywords

BETA 2 MICROGLOBULIN; HLA ANTIBODY; HLA ANTIGEN CLASS 1;

ARTICLE; CLINICAL ARTICLE; FLOW CYTOMETRY; HUMAN; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION;

EID: 0029804655     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1904.x     Document Type: Article

References (17)

1. Brand, A., Claas, F.H.J., Voogt, P.J., Wasser, M.N.J.M, & Eernisse, G.J. (1988) Alloimmunization after leukocyte depleted multiple random donor platelets. Vox Sanguinis, 54, 160-166.
2. Brand, A., van Leeuwen, A., Eernisse, J.G. & van Rood, J.J. (1978) Platelet transfusion therapy: optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests. Blood, 51, 781-783.
3. Kiefel, V. (1992) The MAIPA assay and its application in immunohaematology. Transfusion Medicine, 2, 181-188.
4. Kurata, Y., Oshida, M., Take, H., Furabayashi, T., Nakao, H., Tomiyama, Y., Kanayama, Y., Nagao, N., Okubo, Y., Yonezawa, T. & Tarui, S. (1989) New approach to eliminate HLA class I antigens from platelet surface without cell damage. Vox Sanguinis. 57, 199-204.
5. Lalezari, P. & Driscoll, A.M. (1982) Ability of thrombocytes to acquire HLA specificity from plasma. Blood, 59, 167-170.
6. Mittal, K.D., Mickey, M.R., Singal, D.P. & Terasaki, P.I. (1968) Serotyping for homotransplantation. XVIII. Refinement of the microdroplet lymphocyte cytotoxicity assay. Transplantation. 6, 913-917.
7. Neumüller, J., Tohidast-Akrad, M., Fischer, M. & Mayr, W.R. (1993) Influence of chloroquine or acid treatment of human platelets on the antigenicity of HLA and the thrombocyte-specific glycoproteins Ia/IIa. IIb and IIb/IIIa. Vox Sanguinis, 65, 223-231.
8. Novotny, V.M.J., Huizinga, T.W.J., van Doorn, R., Briet, E. & Brand, A. (1996) HLA class I eluted platelets as alternative to HLA-matched platelet transfusions. Transfusion, 36, 438-444.
9. Novotny, V.M.J., van Doorn, R., Rozier, Y., D'Amaro, J., Harvey, M.S. & Brand, A. (1992) Transfusion results of tiltered and subsequently stored random platelet suspensions prepared from buffy coats. Vox Sanguinis. 63, 23-30.
10. Novotny, V.M.J., van Doorn, R., Witvliet, M.D., Claas, F.H.J. & Brand, A. (1995) Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study. Blood, 85, 1736-1741.
11. Otten, G.R., Bikhoff, E., Ribaudo, R.K., Kozlowski, S., Margulies, D.H. & Germain, R.N. (1992) Peptide and 32-microglobulin regulation of cell surface MHC class I conformation and expression. Journal of Immunology, 148, 3723-3732.
12. Polakova, K., Karpotova, M. & Russ, G. (1993) Dissociation of 32-microglobulin is responsible for selective reduction of HLA class I antigenicity following acid treatment of cells. Molecular Immunology, 30, 1223-1239.
13. Santoso, S., Kalb, R., Kiefel, V. & Mueller-Eckhardt, C. (1993) The presence of messenger RNA for HLA class I in human platelets and its capability for protein biosynthesis. British Journal of Haematology, 84, 451-456.
14. Santoso, S., Mueller-Eckhardt, G., Santoso, S., Kiefel, V. & Mueller Eckhardt, C. (1986) HLA antigens on platelet membranes. Vox Sanguinis. 51, 327-333.
15. Shanwell, A., Sallander, S., Olsson, I., Gullikson, H., Pedajas, I. & Lernen, R. (1991) An alloimmunized thrombocytopenic patient succesfully transfused with acid-treated random donor platelets. British Journal of Haematology, 79, 462-465.
16. Sintnicolaas, K., van Prooyen, M.C., van Marwijk, Kooy, M., van Dijk, B.A., van Putten, W.L.J., Novotny. V.M.J. & Brand, A. (1995) Leukocyte depletion of random single donor platelet transfusions does not prevent secondary HLA-alloimmunization: a randomized prospective study. Blood, 85, 824-828.
17. Sugawara, S., Abo, T. & Kamagia, K. (1987) A simple method to eliminate the antigenicity of surface class I MHC molecules from the membrane of viable cells by acid treatment at pH 3. Journal of Immunological Methods, 100, 83-90.